Search:

Home

HAART

Talking with your patient

> Newly diagnosed

> In treatment

> Caregivers

GSK's commitment

Resources

Important Safety Information/
Indications > LEXIVA^® (fosamprenavir calcium)
> EPZICOM^® (abacavir sulfate and lamivudine)
> COMBIVIR^® (lamivudine/zidovudine)
> TRIZIVIR^® (abacavir sulfate, lamivudine, and zidovudine)
> ZIAGEN^® (abacavir sulfate)
> EPIVIR^® (lamivudine)
> RETROVIR^® (zidovudine)

Site map

Caregivers

Healthcare providers can discuss a patient's medical issues with caregivers who are legally authorized to receive this information. Here are a few pointers for interactions with caregivers:

• Speak with them as if they, too, were partners in the success of treatment, and encourage them to ask questions if they are confused or unclear about anything
• Let them know the importance of their role in promoting adherence, either through keeping track of dosing or encouraging the patient to take doses as scheduled